Campbell Capital Management Inc Zynerba Pharmaceuticals, Inc. Transaction History

Campbell Capital Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 08, 2020	SELL	$3.31 - $6.54 $236,704 - $467,688	-71,512 Closed	0 $0
Q1 2020 Apr 10, 2020	SELL	$2.9 - $6.16 $870 - $1,848	-300 Reduced 0.42%	71,512 $274,000
Q4 2019 Jan 09, 2020	SELL	$5.61 - $8.57 $216,764 - $331,136	-38,639 Reduced 34.98%	71,812 $434,000
Q3 2019 Oct 01, 2019	BUY	$7.56 - $15.44 $95,724 - $195,501	12,662 Added 12.95%	110,451 $835,000
Q2 2019 Jul 18, 2019	SELL	$5.4 - $15.5 $448,189 - $1.29 Million	-82,998 Reduced 45.91%	97,789 $1.33 Million
Q1 2019 Apr 09, 2019	BUY	$3.6 - $6.22 $32,760 - $56,602	9,100 Added 5.3%	180,787 $980,000
Q4 2018 Feb 15, 2019	BUY	$2.89 - $7.91 $496,175 - $1.36 Million	171,687 New	171,687 $510,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Campbell Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Campbell Capital Management Inc with notifications on news.